Author(s): Chang CF, Rashtian A, Gould MK
Abstract Share this page
Abstract This article discusses the potential benefits and limitations of positron emission tomography (PET) for characterizing lung nodules, staging the mediastinum, identifying occult distant metastasis, determining prognosis and treatment response, guiding plans for radiation therapy, restaging during and after treatment, and selecting targets for tissue sampling. The key findings from the medical literature are presented regarding the capabilities and fallibilities of PET in lung cancer evaluation, including characterization of pulmonary nodules and staging in patients with known or suspected non-small-cell lung cancer. The discussion is limited to PET imaging with fluorodeoxyglucose. Copyright Â© 2011 Elsevier Inc. All rights reserved.
This article was published in Clin Chest Med
and referenced in Rheumatology: Current Research